Artykuły w czasopismach na temat „Tumstatin”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Tumstatin”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Wang, Shu Jing, Jia Liu, Fei Wang, Ning Chen, Shan Jiang, Lin Liu, Ying Zhao i Xiao Dan Zhang. "Tumstatin 7 Peptide Affect Biological Activity of B16 Melanoma Cell". Advanced Materials Research 641-642 (styczeń 2013): 915–18. http://dx.doi.org/10.4028/www.scientific.net/amr.641-642.915.
Pełny tekst źródłaBonn, Dorothy. "Tumstatin hints at how angiogenesis inhibitors work". Lancet Oncology 3, nr 2 (luty 2002): 71. http://dx.doi.org/10.1016/s1470-2045(02)00641-1.
Pełny tekst źródłaWANG, WEI, CHUN-XIAO XU, GUO-SHENG HOU, YOU-GEN CHEN, JIA-XUAN XIN i XIAN-XI LIU. "Downregulation of tumstatin expression by overexpression of ornithine decarboxylase". Oncology Reports 30, nr 5 (29.08.2013): 2042–48. http://dx.doi.org/10.3892/or.2013.2708.
Pełny tekst źródłaMaeshima, Y. "Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis". Science 295, nr 5552 (4.01.2002): 140–43. http://dx.doi.org/10.1126/science.1065298.
Pełny tekst źródłaOruc, Y., i S. Aydin. "Blood and aqueous humor tumstatin concentrations associated with diabetic retinopathy". Annals of Systems Biology 3, nr 1 (25.04.2020): 025–28. http://dx.doi.org/10.17352/asb.000008.
Pełny tekst źródłaNissen, Gyde, Henrike Hollaender, Francesca S. M. Tang, Michael Wegmann, Lars Lunding, Christina Vock, Anna Bachmann i in. "Tumstatin fragment selectively inhibits neutrophil infiltration in experimental asthma exacerbation". Clinical & Experimental Allergy 48, nr 11 (28.08.2018): 1483–93. http://dx.doi.org/10.1111/cea.13236.
Pełny tekst źródłaGu, Quliang, Tianyuan Zhang, Jinxian Luo i Fangyu Wang. "Expression, purification, and bioactivity of human tumstatin from Escherichia coli". Protein Expression and Purification 47, nr 2 (czerwiec 2006): 461–66. http://dx.doi.org/10.1016/j.pep.2006.01.011.
Pełny tekst źródłaCaudroy, Stephanie, Joel Cucherousset, Marianne Lorenzato, Jean-Marie Zahm, Corinne Martinella-Catusse, Myriam Polette i Philippe Birembaut. "Implication of tumstatin in tumor progression of human bronchopulmonary carcinomas". Human Pathology 35, nr 10 (październik 2004): 1218–22. http://dx.doi.org/10.1016/j.humpath.2004.06.008.
Pełny tekst źródłaXu, Chun-xiao, Xian-xi Liu, Guo-sheng Hou, Yun-fei Yan, Shi-min Chen, Wei Wang, Guang-shui Jiang, Bin Liu i Jia-xuan Xin. "The expression of tumstatin is down-regulated in renal carcinoma". Molecular Biology Reports 37, nr 5 (18.08.2009): 2273–77. http://dx.doi.org/10.1007/s11033-009-9718-9.
Pełny tekst źródłaWei, C., A. Y. Xun, X. X. Wei, J. Yao, J. Y. Wang, R. Y. Shi, G. H. Yang i in. "BifidobacteriaExpressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice". Technology in Cancer Research & Treatment 15, nr 3 (11.05.2015): 498–508. http://dx.doi.org/10.1177/1533034615581977.
Pełny tekst źródłaWang, Shu Jing, Ning Chen, Zhang Yi, Jia Liu i Bei Bei Xu. "Study on the Biological Activity of Anti-Tumor Peptide of Tumstatin". Advanced Materials Research 183-185 (styczeń 2011): 1509–12. http://dx.doi.org/10.4028/www.scientific.net/amr.183-185.1509.
Pełny tekst źródłaThevenard, Jessica, Nicolas Floquet, Laurent Ramont, Elise Prost, Jean-Marc Nuzillard, Manuel Dauchez, Hocine Yezid i in. "Structural and Antitumor Properties of the YSNSG Cyclopeptide Derived from Tumstatin". Chemistry & Biology 13, nr 12 (grudzień 2006): 1307–15. http://dx.doi.org/10.1016/j.chembiol.2006.10.007.
Pełny tekst źródłaWang, Shujing, Yan Liu, Xuesong Lin, Xue Fu, Jianyong Xu i Xinghan Liu. "Cloning and biological activity of an anti-tumor peptide of Tumstatin". Frontiers of Biology in China 2, nr 3 (lipiec 2007): 276–83. http://dx.doi.org/10.1007/s11515-007-0040-4.
Pełny tekst źródłaLuo, Yi-Qin, Liang-Hua Wang, Qui Yi i Bing-Hua Jiao. "Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli". Clinical and Experimental Medicine 8, nr 1 (marzec 2008): 37–42. http://dx.doi.org/10.1007/s10238-008-0154-2.
Pełny tekst źródłaBurgess, Janette K., Sarah Boustany, Lyn M. Moir, Markus Weckmann, Justine Y. Lau, Karryn Grafton, Melissa Baraket i in. "Reduction of Tumstatin in Asthmatic Airways Contributes to Angiogenesis, Inflammation, and Hyperresponsiveness". American Journal of Respiratory and Critical Care Medicine 181, nr 2 (15.01.2010): 106–15. http://dx.doi.org/10.1164/rccm.200904-0631oc.
Pełny tekst źródłaZhang, Pengguo, Qingwei Zhou, Lin Tian, Xiangyu Zhou, Yue Zhou i Jiajun Chen. "Experimental study of a novel tumstatin on C6 brain glioma in vitro". Oncology Letters 14, nr 3 (30.06.2017): 2845–51. http://dx.doi.org/10.3892/ol.2017.6507.
Pełny tekst źródłaMaeshima, Yohei, Mark Manfredi, Corinne Reimer, Kathryn A. Holthaus, Helmut Hopfer, Babi R. Chandamuri, Surender Kharbanda i Raghu Kalluri. "Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin". Journal of Biological Chemistry 276, nr 18 (7.02.2001): 15240–48. http://dx.doi.org/10.1074/jbc.m007764200.
Pełny tekst źródłaLuo, Yi-Qin, Zhou Ming, Liang Zhao, Li-Juan Yao, Hang Dong, Jian-Ping Du, Shuang-Zheng Wu i Wen Hu. "Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC". IUBMB Life 64, nr 5 (31.03.2012): 423–31. http://dx.doi.org/10.1002/iub.1016.
Pełny tekst źródłaLi, Juan, Jing Luo, Yi-Qin Luo, Ming Zhou, Liang Zhao, Li-Juan Yao, Hang Dong i Rui-Ning Yang. "Overexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets". Transfusion 54, nr 8 (24.03.2014): 2106–17. http://dx.doi.org/10.1111/trf.12617.
Pełny tekst źródłaLi, Ying-jie, Li-chun Sun, Yan He, Xing-han Liu, Miao Liu, Qi-min Wang i Xiao-ming Jin. "The anti-tumor properties of two tumstatin peptide fragments in human gastric carcinoma". Acta Pharmacologica Sinica 30, nr 9 (24.08.2009): 1307–15. http://dx.doi.org/10.1038/aps.2009.111.
Pełny tekst źródłaYasuda, Jumpei, Muneyoshi Okada i Hideyuki Yamawaki. "T3 peptide, a fragment of tumstatin, prevents the ischemia-reperfusion injury in cardiomyocytes". Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 (2018): PO1–2–65. http://dx.doi.org/10.1254/jpssuppl.wcp2018.0_po1-2-65.
Pełny tekst źródłaSun, Chao, Dongyang He, Chao Ma, Zhenyue Gao, Yijun Chen i Shuzhen Wang. "Bifunctional Fusion Proteins Derived from Tumstatin and 4-1BBL for Targeted Cancer Therapy". Molecular Pharmaceutics 16, nr 2 (19.12.2018): 867–76. http://dx.doi.org/10.1021/acs.molpharmaceut.8b01190.
Pełny tekst źródłaHarkness, Louise Margaret, Markus Weckmann, Matthias Kopp, Tim Becker, Anthony Wayne Ashton i Janette Kay Burgess. "Tumstatin regulates the angiogenic and inflammatory potential of airway smooth muscle extracellular matrix". Journal of Cellular and Molecular Medicine 21, nr 12 (13.06.2017): 3288–97. http://dx.doi.org/10.1111/jcmm.13232.
Pełny tekst źródłaMaeshima, Yohei, Pablo C. Colorado i Raghu Kalluri. "Two RGD-independent αvβ3Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties". Journal of Biological Chemistry 275, nr 31 (2.06.2000): 23745–50. http://dx.doi.org/10.1074/jbc.c000186200.
Pełny tekst źródłaGu, Quliang, Cihuang Sun, Jinxian Luo, Tianyuan Zhang i Lijing Wang. "Inhibition of angiogenesis by a synthetic fusion protein VTF derived from vasostatin and tumstatin". Anti-Cancer Drugs 25, nr 9 (październik 2014): 1044–51. http://dx.doi.org/10.1097/cad.0000000000000134.
Pełny tekst źródłaZan, Jinhang, Xin He, Wei Long i Peixun Liu. "Insights into binding modes of tumstatin peptide T7 with the active site of αvβ3integrin". Molecular Simulation 38, nr 6 (maj 2012): 498–508. http://dx.doi.org/10.1080/08927022.2011.649428.
Pełny tekst źródłaNaling, Song, He Xin, Zhao Qiren, Yan Tingdong i Wen Lei. "Cloning and expression of the tumstatin active peptides-T7 and its derivant-T7-NGR". Clinical and Experimental Medicine 9, nr 2 (3.02.2009): 165–71. http://dx.doi.org/10.1007/s10238-008-0029-6.
Pełny tekst źródłaWang, Shu Jing, Shan Jiang, Jia Liu, Fei Wang, Ning Chen, Lin Liu, Ying Zhao i Xiao Dan Zhang. "The Effect of T-7 Peptide on Human Non-Small-Cell Carcinoma A549 Cells". Advanced Materials Research 641-642 (styczeń 2013): 820–23. http://dx.doi.org/10.4028/www.scientific.net/amr.641-642.820.
Pełny tekst źródłaWang, Shu Jing, Fei Wang, Jia Liu, Shan Jiang, Ning Chen, Lin Liu, Ying Zhao i Xiao Dan Zhang. "Effect of Tumstatin T-7 Peptide on HepG-2 Cells and Human Umbilical Vein Endothelial Cells". Advanced Materials Research 641-642 (styczeń 2013): 744–47. http://dx.doi.org/10.4028/www.scientific.net/amr.641-642.744.
Pełny tekst źródłaS Boosani, Chandra, Ashok K Verma i Akulapalli Sudhakar. "Validation of Different Systems for Tumstatin Expression and its in-vitro and iv-vivo Activities". Journal of Cancer Science & Therapy 01, nr 01 (2009): 008–18. http://dx.doi.org/10.4172/1948-5956.1000002.
Pełny tekst źródłaYao, Bin, Qiu-Ming He, Ling Tian, Fei Xiao, Yu Jiang, Ru Zhang, Gang Li i in. "Enhanced Antitumor Effect of the Combination of Tumstatin Gene Therapy and Gemcitabine in Murine Models". Human Gene Therapy 16, nr 9 (wrzesień 2005): 1075–86. http://dx.doi.org/10.1089/hum.2005.16.1075.
Pełny tekst źródłaSun, Chao, Dongyang He, Chao Ma, Zhenyue Gao, Yijun Chen i Shuzhen Wang. "Correction to “Bifunctional Fusion Proteins Derived from Tumstatin and 4–1BBL for Targeted Cancer Therapy”". Molecular Pharmaceutics 16, nr 12 (14.11.2019): 5085. http://dx.doi.org/10.1021/acs.molpharmaceut.9b01144.
Pełny tekst źródłaChang, Kyung Hwa, Jong Min Lee, Hee Kyoung Jeon i In Sik Chung. "Improved production of recombinant tumstatin in stably transformed Trichoplusia ni BTI Tn 5B1-4 cells". Protein Expression and Purification 35, nr 1 (maj 2004): 69–75. http://dx.doi.org/10.1016/j.pep.2004.01.004.
Pełny tekst źródłaEsipov, Roman, Ksenia Beyrakhova, Vera Likhvantseva, Evgenia Stepanova, Vasily Stepanenko, Maria Kostromina, Yulia Abramchik i Anatoly Miroshnikov. "Antiangiogenic and antivascular effects of a recombinant tumstatin-derived peptide in a corneal neovascularization model". Biochimie 94, nr 6 (czerwiec 2012): 1368–75. http://dx.doi.org/10.1016/j.biochi.2012.03.007.
Pełny tekst źródłaREN, Na, Liang-hua WANG, Yun GAO, Ming-juan SUN, Yu-liang JIAO, Ai-yun GUO i Bing-hua JIAO. "Expression of Tumstatin183-230-TRAIL fusion protein and identification of its biological functions". Academic Journal of Second Military Medical University 28, nr 5 (13.10.2008): 474–78. http://dx.doi.org/10.3724/sp.j.1008.2008.00474.
Pełny tekst źródłaWANG, YANG, RUO-FENG YIN i JIA-SONG TENG. "Tumstatin induces apoptosis and stimulates phosphorylation of p65NF-κB in human osteoblastic osteosarcoma Saos-2 cells". Oncology Reports 35, nr 6 (20.04.2016): 3403–8. http://dx.doi.org/10.3892/or.2016.4762.
Pełny tekst źródłaYamamoto, Y., Y. Maeshima, H. Kitayama, S. Kitamura, Y. Takazawa, H. Sugiyama, Y. Yamasaki i H. Makino. "Tumstatin Peptide, an Inhibitor of Angiogenesis, Prevents Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy". Diabetes 53, nr 7 (25.06.2004): 1831–40. http://dx.doi.org/10.2337/diabetes.53.7.1831.
Pełny tekst źródłaFolkman, J. "Tumor Suppression by p53 Is Mediated in Part by the Antiangiogenic Activity of Endostatin and Tumstatin". Science's STKE 2006, nr 354 (19.09.2006): pe35. http://dx.doi.org/10.1126/stke.3542006pe35.
Pełny tekst źródłaThevenard, Jessica, Laurent Ramont, Lluis M. Mir, Aurélie Dupont-Deshorgue, François-Xavier Maquart, Jean-Claude Monboisse i Sylvie Brassart-Pasco. "A new anti-tumor strategy based on in vivo tumstatin overexpression after plasmid electrotransfer in muscle". Biochemical and Biophysical Research Communications 432, nr 4 (marzec 2013): 549–52. http://dx.doi.org/10.1016/j.bbrc.2013.02.074.
Pełny tekst źródłaHWANG-BO, JEON, JONG-HWA PARK i IN SIK CHUNG. "Tumstatin induces apoptosis mediated by Fas signaling pathway in oral squamous cell carcinoma SCC-VII cells". Oncology Letters 10, nr 2 (25.05.2015): 1016–22. http://dx.doi.org/10.3892/ol.2015.3261.
Pełny tekst źródłaZHANG, Guang-mei, Ying-mei ZHANG, Song-bin FU, Xing-han LIU, Xue FU, Yan YU i Zhi-yi ZHANG. "Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells". Chinese Medical Journal 121, nr 22 (listopad 2008): 2324–30. http://dx.doi.org/10.1097/00029330-200811020-00020.
Pełny tekst źródłaTanabe, Katsuyuki, Yohei Maeshima, Yasufumi Sato i Jun Wada. "Antiangiogenic Therapy for Diabetic Nephropathy". BioMed Research International 2017 (2017): 1–12. http://dx.doi.org/10.1155/2017/5724069.
Pełny tekst źródłaSudhakar, Akulapalli, i Chandra S. Boosani. "Retraction Note: Inhibition of Tumor Angiogenesis by Tumstatin: Insights into Signaling Mechanisms and Implications in Cancer Regression". Pharmaceutical Research 38, nr 2 (15.01.2021): 377. http://dx.doi.org/10.1007/s11095-020-02974-x.
Pełny tekst źródłaHe, Yan, Yang Jiang, Ying-Jie Li, Xing-Han Liu, Lei Zhang, Li-Juan Liu, Hang Shi, Hui-Ning Li, Yong-Cu Ma i Xiao-Ming Jin. "19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cellsin vitroandin vivo". Journal of Gastroenterology and Hepatology 25, nr 5 (28.04.2010): 935–41. http://dx.doi.org/10.1111/j.1440-1746.2009.06209.x.
Pełny tekst źródłaSudhakar, A., H. Sugimoto, C. Yang, J. Lively, M. Zeisberg i R. Kalluri. "Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by v 3 and 5 1 integrins". Proceedings of the National Academy of Sciences 100, nr 8 (7.04.2003): 4766–71. http://dx.doi.org/10.1073/pnas.0730882100.
Pełny tekst źródłaYasuda, Jumpei, Muneyoshi Okada i Hideyuki Yamawaki. "Protective effect of T3 peptide, an active fragment of tumstatin, against ischemia/reperfusion injury in rat heart". Journal of Pharmacological Sciences 139, nr 3 (marzec 2019): 193–200. http://dx.doi.org/10.1016/j.jphs.2019.01.010.
Pełny tekst źródłaYasuda, Jumpei, Muneyoshi Okada i Hideyuki Yamawaki. "T3 peptide, an active fragment of tumstatin, inhibits H 2 O 2 -induced apoptosis in H9c2 cardiomyoblasts". European Journal of Pharmacology 807 (lipiec 2017): 64–70. http://dx.doi.org/10.1016/j.ejphar.2017.04.032.
Pełny tekst źródłaPasco, Sylvie, Laurent Ramont, Lydie Venteo, Michel Pluot, François-Xavier Maquart i Jean-Claude Monboisse. "In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model". Experimental Cell Research 301, nr 2 (grudzień 2004): 251–65. http://dx.doi.org/10.1016/j.yexcr.2004.07.036.
Pełny tekst źródłaEikesdal, H. P., H. Sugimoto, G. Birrane, Y. Maeshima, V. G. Cooke, M. Kieran i R. Kalluri. "Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity". Proceedings of the National Academy of Sciences 105, nr 39 (25.09.2008): 15040–45. http://dx.doi.org/10.1073/pnas.0807055105.
Pełny tekst źródłaYu, Wei, Jun'an Hu, Haiwei Le, Yigao Lu, Weihua Xu, Wangfang Yu i Wei Shen. "Tumstatin attenuates the promotion effect of IL-17 secreted by Th17 cells on the stemness maintenance of glioma cells". Pathology - Research and Practice 223 (lipiec 2021): 153463. http://dx.doi.org/10.1016/j.prp.2021.153463.
Pełny tekst źródła